Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers

NCT00852995 is registered in ClinicalTrials.gov with Healthpoint as lead sponsor.

NCT NCT00852995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00852995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Lead sponsor
Healthpoint
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
July 31, 2011
Enrollment
228 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer, venous stasis ulcers